A case of Crohn's disease combined with inflammatory myofibroblastoma of abdominal wall.
10.11817/j.issn.1672-7347.2021.200966
- Author:
Zhongcheng LIU
1
;
Qian CHEN
2
;
Meichun LONG
3
;
Tian HE
3
;
Qin GUO
4
Author Information
1. Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013. 2997709332@qq.com.
2. Department of Pathology, Third Xiangya Hospital, Central South University, Changsha 410013.
3. Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013.
4. Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013. xyldgq@126.com.
- Publication Type:Journal Article
- Keywords:
Crohn's disease;
abdominal wall;
inflammatory myofibroblastoma
- MeSH:
Abdominal Pain;
Abdominal Wall/surgery*;
Crohn Disease/complications*;
Humans;
Intestine, Small;
Male;
Neoplasms, Muscle Tissue/surgery*
- From:
Journal of Central South University(Medical Sciences)
2021;46(11):1310-1314
- CountryChina
- Language:English
-
Abstract:
Inflammatory myofibroblastoma (IMT) is a rare solid tumor, and its etiology and pathogenesis are unclear. Crohn's disease is a non-specific intestinal inflammatory disease. The clinical manifestations, laboratory examinations, and imaging examinations of IMT are not specific, making diagnosis difficult. A case of Crohn's disease combined with IMT of abdominal wall was admitted to the Department of Gastroenterology at the Third Xiangya Hospital, Central South University, on Nov. 21, 2017. This patient was admitted to our hospital because of repeated right lower abdominal pain for 4 years. A 6 cm×5 cm mass was palpated in the right lower abdomen. After completing the transanal double-balloon enteroscopy and computed tomographic enterography for the small intestinal, the cause was still unidentified. The patient underwent surgery due to an abdominal wall mass with intestinal fistula on Sept. 12, 2018 and recovered well currently. According to histopathology and immunohistochemistry, he was diagnosed with Crohn's disease combined with IMT. Up to July 2020, the patients still took azathioprine regularly, without abdominal pain, abdominal distension, and other discomfort, and the quality of his life was good.
